Integragen

SME

Integragen

Description

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in cutting edge genomic services to academic researchers and life sciences companies based on its technological expertise and scientific know how.

Referent Contact

Emmanuel Martin

emmanuel.martin@integragen.com

Integragen

Address

5, rue Henri Desbruères
91000 Evry-Courcouronnes, Ile de France, France

Contact

contact@integragen.com

Description

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in cutting edge genomic services to academic researchers and life sciences companies based on its technological expertise and scientific know how.

Matchmaking

Connect with Integragen

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

Integragen last news

10/10/2023

SÉMINAIRE DE GÉNÉTIQUE CLINIQUE À ANGERS

Rejoignez-nous lors du 33ème séminaire de génétique clinique les 2 et 3 février 2023 à Angers. Thomas Bolzec et Mira Ayadi vous attendent avec plaisir sur notre stand pour discuter de vos projets de génomique. N'hésitez pas à les contacter pour prendre rendez-vous : services@integragen.com #content-main{display:none} For full functionality (…) (+) The post SÉMINAIRE DE GÉNÉTIQUE CLINIQUE À ANGERS appeared first on Integragen .

13/07/2023

IntegraGen reports €5.6m in revenues for H1 2023 representing 13% decrease compared to H1 2022 and a cash position of €4.3m

Decline in microbiology sequencing platform activity after a strong contribution in the first half of 2022 in connection with the Covid-19 pandemic. Adjusted for this base effect, growth was 6% over the period. Slight decrease in revenues recognized by the Evry R&D sequencing platform. Evry, France, Thursday July (…) (…) (+) The post IntegraGen reports €5.6m in revenues for H1 2023 representing 13% decrease compared to H1 2022 and a cash position of €4.3m appeared first on Integragen .

24/04/2023

IntegraGen reports 2022 annual results with a growth of 16% in revenues and a positive EBITDA.

Increase of activities performed on all sequencing platforms Positive EBITDA for the second consecutive year despite inflation impact on reagents Growth outlook confirmed for 2023 Evry, France, april 24th 2023, 6 pm – IntegraGen (FR0010908723 – ALINT – Eligible PEA PME) , IntegraGen , a company specializing in the decryption of the (…) (…) (…) (+) The post IntegraGen reports 2022 annual results with a growth of 16% in revenues and a positive EBITDA. appeared first on Integragen .